News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lunger John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 3,843 shares
@ $1.7468, valued at
$6.7k
Sold 4,973 shares
@ $1.706, valued at
$8.5k
|
|
| 01/04/2023 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 1,100 shares
@ $1.694, valued at
$1.9k
|
|
| 08/01/2022 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 2,983 shares
@ $1.7735, valued at
$5.3k
|
|
| 07/05/2022 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 1,973 shares
@ $1.6781, valued at
$3.3k
|
|
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/18/2022 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 4,368 shares
@ $3.1918, valued at
$13.9k
|
|
| 01/13/2022 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,407,072 options to buy
@ $0
Granted 314,256 options to buy
@ $0 |
|
| 01/13/2022 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 3,770 shares
@ $3.5567, valued at
$13.4k
Sold 1,076 shares
@ $3.5441, valued at
$3.8k
|
|
| 01/05/2022 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 1,070 shares
@ $4.0642, valued at
$4.3k
|
|
| 08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 4,823 shares
@ $9.25, valued at
$44.6k
|
|
| 01/17/2020 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,257,744 options to buy
@ $0
Granted 280,896 options to buy
@ $0 |
|
| 01/15/2020 |
4
| Lunger John (Chief Patient Supply Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 1,144 shares
@ $5.1347, valued at
$5.9k
|
|
| 01/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|